<code id='56889648DA'></code><style id='56889648DA'></style>
    • <acronym id='56889648DA'></acronym>
      <center id='56889648DA'><center id='56889648DA'><tfoot id='56889648DA'></tfoot></center><abbr id='56889648DA'><dir id='56889648DA'><tfoot id='56889648DA'></tfoot><noframes id='56889648DA'>

    • <optgroup id='56889648DA'><strike id='56889648DA'><sup id='56889648DA'></sup></strike><code id='56889648DA'></code></optgroup>
        1. <b id='56889648DA'><label id='56889648DA'><select id='56889648DA'><dt id='56889648DA'><span id='56889648DA'></span></dt></select></label></b><u id='56889648DA'></u>
          <i id='56889648DA'><strike id='56889648DA'><tt id='56889648DA'><pre id='56889648DA'></pre></tt></strike></i>

          knowledge

          knowledge

          author:leisure time    Page View:3
          Photo illustration of a checkbook wrapped with lock and chain – hospital and investment coverage from STAT
          Alex Hogan/STAT

          Hospitals once dove headfirst into venture capital with splashy headlines and attention-grabbing numbers. Now, in an era of flattened margins and exceedingly uncertain returns, many health systems are quietly pulling back.

          NewYork-Presbyterian’s venture firm, once managing roughly $40 million in assets, was essentially dissolved, two former employees said, with leaders punting it from the system’s strategy division to innovation, then from innovation to the investment office — a spokesperson described it as being “integrated” into the broader strategy. PitchBook data show no investments after 2020.

          advertisement

          Advocate Health Enterprises, meanwhile, the venture firm of a 67-hospital system based in Charlotte, N.C., has lost at least six employees within the past year, including its president, from a staff that once included about a dozen people.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          Sana to lay off nearly a third of staff, de
          Sana to lay off nearly a third of staff, de

          Illustrationofatealcancercell.AdobeSanaBiotechnology,astartupthatjustacoupleofyearsagoraisedover$1bi

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Merck, Daiichi strike cancer drug pact worth up to $22 billion

          KenaBetancur/GettyImagesMADRID—MerckispayingbillionsofdollarstopartnerwithDaiichiSankyoonaseriesofca